Statins, risk assessment, and the new American prevention guidelines

Lancet. 2014 Feb 15;383(9917):600-2. doi: 10.1016/S0140-6736(13)62348-X. Epub 2013 Dec 4.

Authors

Donald M Lloyd-Jones¹, David Goff², Neil J Stone³

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago 60611, IL, USA. Electronic address: dlj@northwestern.edu.
² Colorado School of Public Health, Aurora, CO, USA.
³ Northwestern University Feinberg School of Medicine, Chicago 60611, IL, USA.

PMID: 24315619
DOI: 10.1016/S0140-6736(13)62348-X

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases / prevention & control*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Practice Guidelines as Topic*
Primary Prevention*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors